Alessandro de Nicola
Président chez AVIO S.P.A.
Postes actifs de Alessandro de Nicola
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVIO S.P.A. | Président | - | - |
| NEXTRA INNXTR INV | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
| The Adam Smith Society | President | 01/01/1993 | - |
Orrick, Herrington & Sutcliffe (Italy)
 Orrick, Herrington & Sutcliffe (Italy) Miscellaneous Commercial ServicesCommercial Services Part of Orrick, Herrington & Sutcliffe LLP, Orrick, Herrington & Sutcliffe (Italy) is a legal services provider. The company is based in Milan, Italy. | Corporate Officer/Principal | - | - |
Historique de carrière de Alessandro de Nicola
Anciens postes connus de Alessandro de Nicola
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LEONARDO S.P.A. | Directeur/Membre du Conseil | 15/05/2014 | - |
| Independent Dir/Board Member | 15/05/2014 | - | |
| MOLMED S.P.A. | Directeur/Membre du Conseil | 07/07/2010 | - |
| Independent Dir/Board Member | 16/03/2011 | - |
Formation de Alessandro de Nicola
| Università Cattolica del Sacro Cuore Campus di Milano | Graduate Degree |
Statistiques
Internationale
| Italie | 8 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Graduate Degree | 1 |
Sectorielle
| Electronic Technology | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LEONARDO S.P.A. | Electronic Technology |
| AVIO S.P.A. | Electronic Technology |
| Entreprise privées | 4 |
|---|---|
AGC Biologics SpA
 AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
| The Adam Smith Society | |
Orrick, Herrington & Sutcliffe (Italy)
Orrick, Herrington & Sutcliffe (Italy) Miscellaneous Commercial ServicesCommercial Services Part of Orrick, Herrington & Sutcliffe LLP, Orrick, Herrington & Sutcliffe (Italy) is a legal services provider. The company is based in Milan, Italy. | Commercial Services |
Amundi Re Italia
 Amundi Re Italia Investment Trusts/Mutual FundsMiscellaneous Amundi Re Italia is a closed-end investment fund. It operates as a real estate fund. The company is headquartered in Milan, Italy. | Miscellaneous |
- Bourse
- Insiders
- Alessandro de Nicola
- Expérience
